Article
It's hard to argue with the statement that no ischemia is probably better than some ischemia, but at what cost?
Enrollment goal met in phase 3 SOLAR-RECUR trial
Former MLB player Dave Winfield shares lessons from baseball, philanthropy
FDA accepts sNDA for darolutamide plus ADT in mHSPC
Key updates from the AUA/ASRM male infertility guideline amendment
Phase 1/2 trial launches of CAR T cell therapy for ccRCC
Dean Laganosky, M.D., named Urology Trailblazer for 2024